{"id":541,"date":"2025-10-17T08:03:43","date_gmt":"2025-10-17T08:03:43","guid":{"rendered":"https:\/\/accelyspharma.com\/?p=541"},"modified":"2025-11-14T08:14:23","modified_gmt":"2025-11-14T08:14:23","slug":"renalys-pharma-reaches-japan-pmda-agreement-on-phase-iii-clinical-trials-of-sparsentan-for-focal-segmental-glomerulosclerosis-fsgs-and-alport-syndrome-as","status":"publish","type":"post","link":"https:\/\/accelyspharma.com\/ja\/renalys-pharma-reaches-japan-pmda-agreement-on-phase-iii-clinical-trials-of-sparsentan-for-focal-segmental-glomerulosclerosis-fsgs-and-alport-syndrome-as\/","title":{"rendered":"\u30ec\u30ca\u30ea\u30b9\u30d5\u30a1\u30fc\u30de\u3001\u5de3\u72b6\u5206\u7bc0\u6027\u7cf8\u7403\u4f53\u786c\u5316\u75c7(FSGS)\u53ca\u3073\u30a2\u30eb\u30dd\u30fc\u30c8\u75c7\u5019\u7fa4(AS)\u306b\u5bfe\u3059\u308bsparsentan\u306e\u56fd\u5185\u7b2c\u2162\u76f8\u81e8\u5e8a\u8a66\u9a13\u958b\u767a\u8a08\u753b\u306b\u3064\u3044\u3066PMDA\u3068\u5408\u610f"},"content":{"rendered":"\n<p>\u30ec\u30ca\u30ea\u30b9\u30d5\u30a1\u30fc\u30de\u682a\u5f0f\u4f1a\u793e\uff08\u672c\u793e\uff1a\u6771\u4eac\u90fd\u4e2d\u592e\u533a\u3001\u4ee5\u4e0b\u300c\u30ec\u30ca\u30ea\u30b9\u30d5\u30a1\u30fc\u30de\u300d\uff09\u306fsparsentan\uff08\u958b\u767a\u30b3\u30fc\u30c9\uff1aRE-021\uff09\u306e\u5de3\u72b6\u5206\u7bc0\u6027\u7cf8\u7403\u4f53\u786c\u5316\u75c7\uff08FSGS\uff09\u306e\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f\u7b2cIII\u76f8\u81e8\u5e8a\u8a66\u9a13\u53ca\u3073\u30a2\u30eb\u30dd\u30fc\u30c8\u75c7\u5019\u7fa4\uff08AS\uff09\u306e\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f\u7b2cIII\u76f8\u81e8\u5e8a\u8a66\u9a13\u306e\u958b\u767a\u8a08\u753b\u306b\u95a2\u3057\u3066\u3001\u72ec\u7acb\u884c\u653f\u6cd5\u4eba\u533b\u85ac\u54c1\u533b\u7642\u6a5f\u5668\u7dcf\u5408\u6a5f\u69cb\uff08PMDA\uff09\u3068\u5408\u610f\u3057\u305f\u4e8b\u3092\u304a\u77e5\u3089\u305b\u3057\u307e\u3059\u3002<\/p>\n\n\n\n<p>\u3053\u308c\u3089\uff12\u8a66\u9a13\u306f\u5c11\u6570\u306e\u60a3\u8005\u3092\u5bfe\u8c61\u306b\u3057\u305f\u975e\u76f2\u691c\u975e\u5bfe\u7167\u306e\u591a\u65bd\u8a2d\u5171\u540c\u81e8\u5e8a\u8a66\u9a13\u3068\u3057\u3066\u5b9f\u65bd\u3092\u8a08\u753b\u3057\u3066\u304a\u308a\u3001\u73fe\u5728\u3001\u6cbb\u9a13\u8a08\u753b\u5c4a\u306e\u63d0\u51fa\u306b\u5411\u3051\u3066\u6e96\u5099\u3092\u9032\u3081\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n<p>\u30ec\u30ca\u30ea\u30b9\u30d5\u30a1\u30fc\u30de\u306f\u3001\u814e\u95a2\u9023\u75be\u60a3\u306b\u304a\u3051\u308b\u9769\u65b0\u7684\u306a\u6cbb\u7642\u85ac\u306e\u958b\u767a\u3092\u901a\u3058\u3066\u65e5\u672c\u53ca\u3073\u30a2\u30b8\u30a2\u306e\u60a3\u8005\u3055\u3093\u306b\u3088\u308a\u826f\u3044\u6cbb\u7642\u3092\u304a\u5c4a\u3051\u3059\u3079\u304f\u3001\u4e8b\u696d\u3092\u63a8\u9032\u3057\u3066\u53c2\u308a\u307e\u3059\u3002<\/p>\n\n\n\n<p><strong>sparsentan\u306b\u3064\u3044\u3066<br><\/strong>sparsentan\u306fTravere Therapeutics, Inc.\uff08\u4ee5\u4e0b\u300cTravere\u300d\uff09\u304c\u958b\u767a\u3057\u305f\u3001\u7d4c\u53e3\u6295\u4e0e\u53ef\u80fd\u306a\u30a8\u30f3\u30c9\u30bb\u30ea\u30f3\u53d7\u5bb9\u4f53\u3068\u30a2\u30f3\u30b8\u30aa\u30c6\u30f3\u30b7\u30f3\u2161\u53d7\u5bb9\u4f53\u306e\u53cc\u65b9\u306b\u5bfe\u3057\u3066\u62ee\u6297\u4f5c\u7528\u3092\u6709\u3059\u308b\u4e8c\u91cd\u62ee\u6297\u85ac\u3067\u3059\u3002\u5f53\u793e\u306f2023\u5e74\u306bTravere\u304b\u3089\u65e5\u672c\u304a\u3088\u3073\u30a2\u30b8\u30a2\u5730\u57df\u3067\u306e\u72ec\u5360\u7684\u958b\u767a\u30fb\u5546\u696d\u5316\u306b\u95a2\u3059\u308b\u30e9\u30a4\u30bb\u30f3\u30b9\u3092\u53d6\u5f97\u3057\u3066\u3044\u307e\u3059\u3002\u56fd\u5185\u3067\u306fIgA\u814e\u75c7\u306e\u7b2cIII\u76f8\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u5168\u8a55\u4fa1\u5bfe\u8c61\u75c7\u4f8b\u306e\u4e3b\u8981\u8a55\u4fa1\u9805\u76ee\u30c7\u30fc\u30bf\u53d6\u5f97\u3092\u5b8c\u4e86\u3057\u30012025\u5e74\u7b2c4\u56db\u534a\u671f\u4e2d\u306b\u30c8\u30c3\u30d7\u30e9\u30a4\u30f3\u30c7\u30fc\u30bf\u3092\u516c\u8868\u3059\u308b\u4e88\u5b9a\u3067\u3059\u3002Travere\u306f2024\u5e74\u306bsparsentan\uff08\u7c73\u56fd\u5546\u54c1\u540d\uff1aFILSPARI\u00ae\uff09\u306b\u3064\u3044\u3066\u3001\u300c\u75c5\u52e2\u9032\u884c\u306e\u30ea\u30b9\u30af\u304c\u3042\u308b\u539f\u767a\u6027IgA\u814e\u75c7\u306e\u6210\u4eba\u60a3\u8005\u306b\u304a\u3051\u308b\u814e\u6a5f\u80fd\u4f4e\u4e0b\u306e\u6291\u5236\u300d\u3092\u52b9\u80fd\u30fb\u52b9\u679c\u3068\u3057\u3066FDA\u304b\u3089\u5b8c\u5168\u627f\u8a8d\u3092\u5f97\u3066\u304a\u308a\u307e\u3059\u3002FILSPARI\u00ae\u306fIgA\u814e\u75c7\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f\u30a4\u30eb\u3079\u30b5\u30eb\u30bf\u30f3\u3068\u306e\u76f4\u63a5\u6bd4\u8f03\u8a66\u9a13\uff08PROTECT\u8a66\u9a13\uff09\u306b\u304a\u3044\u3066\u3001\u86cb\u767d\u5c3f\u306e\u6709\u610f\u306a\u6e1b\u5c11\u3001\u814e\u6a5f\u80fd\u306e\u7dad\u6301\u3001\u5fcd\u5bb9\u6027\u306e\u9ad8\u3044\u5b89\u5168\u6027\u30d7\u30ed\u30d5\u30a1\u30a4\u30eb\u3092\u793a\u3057\u307e\u3057\u305f\u3002\u6b27\u5dde\u306b\u304a\u3044\u3066\u30822025\u5e74\u306bIgA\u814e\u75c7\u306e\u9069\u5fdc\u75c7\u306b\u3066EU\u6a19\u6e96\u627f\u8a8d\u3092\u53d6\u5f97\u3057\u3066\u3044\u307e\u3059\u3002\u307e\u305f\u30012025\u5e74\u306bFILSPARI\u00ae\u306f\u3001\u300c\u5de3\u72b6\u5206\u7bc0\u6027\u7cf8\u7403\u4f53\u786c\u5316\u75c7\uff08FSGS\uff09\u300d\u3092\u52b9\u80fd\u30fb\u52b9\u679c\u3068\u3057\u3066FDA\u306b\u8ffd\u52a0\u65b0\u85ac\u627f\u8a8d\u7533\u8acb\uff08sNDA\uff09\u304c\u53d7\u7406\u3055\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n<p><strong>\u5de3\u72b6\u5206\u7bc0\u6027\u7cf8\u7403\u4f53\u786c\u5316\u75c7\uff08<\/strong><strong>FSGS\uff09\u306b\u3064\u3044\u3066<br><\/strong>FSGS\u306f\u3001\u814e\u4e0d\u5168\u306e\u91cd\u8981\u306a\u539f\u56e0\u306e\u3072\u3068\u3064\u3068\u3057\u3066\u77e5\u3089\u308c\u3001\u672c\u75c7\u3092\u539f\u56e0\u3068\u3057\u3066\u672b\u671f\u814e\u4e0d\u5168\uff08\u900f\u6790\uff09\u3078\u3068\u9032\u884c\u3059\u308b\u60a3\u8005\u3055\u3093\u304c\u5c11\u306a\u304f\u3042\u308a\u307e\u305b\u3093\u3002FSGS\u306f\u3001\u7cf8\u7403\u4f53\u306e\u4e00\u90e8\uff08\u5de3\u72b6\uff09\u304b\u3064\u5206\u7bc0\u7684\u306b\u786c\u5316\u304c\u751f\u3058\u3001\u814e\u81d3\u306e\u6ffe\u904e\u6a5f\u80fd\u3092\u969c\u5bb3\u3059\u308b\u3053\u3068\u3067\u767a\u75c7\u3059\u308b\u3068\u8003\u3048\u3089\u308c\u3066\u304a\u308a\u3001\u6307\u5b9a\u96e3\u75c5\u3067\u3042\u308b\u4e00\u6b21\u6027\u30cd\u30d5\u30ed\u30fc\u30bc\u75c7\u5019\u7fa4\uff08\u6307\u5b9a\u96e3\u75c5222\uff09\u306e\u4e00\u3064\u3068\u3055\u308c\u3066\u3044\u307e\u3059\u3002FSGS\u306f\u767a\u75c7\u3084\u9032\u5c55\u306e\u6b63\u78ba\u306a\u30e1\u30ab\u30cb\u30ba\u30e0\u306f\u672a\u89e3\u660e\u306a\u90e8\u5206\u304c\u591a\u304f\u3001\u30b9\u30c6\u30ed\u30a4\u30c9\u62b5\u6297\u6027\u4f8b\u3082\u5b58\u5728\u3059\u308b\u305f\u3081\u6cbb\u7642\u306b\u96e3\u6e0b\u3059\u308b\u75c7\u4f8b\u304c\u5c11\u306a\u304f\u3042\u308a\u307e\u305b\u3093\u3002\u73fe\u72b6\u3001\u65e5\u672c\u306b\u304a\u3044\u3066\u306fFSGS\u306b\u5bfe\u3059\u308b\u6cbb\u7642\u6cd5\u306f\u9650\u3089\u308c\u3066\u304a\u308a\u3001\u5927\u304d\u306a\u30a2\u30f3\u30e1\u30c3\u30c8\u30cb\u30fc\u30ba\u304c\u5b58\u5728\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n<p><strong>\u30a2\u30eb\u30dd\u30fc\u30c8\u75c7\u5019\u7fa4\uff08<\/strong><strong>AS\uff09\u306b\u3064\u3044\u3066<br><\/strong>AS\u306f\u3001\u5c0f\u5150\u671f\u304b\u3089\u8840\u5c3f\u3084\u86cb\u767d\u5c3f\u306a\u3069\u306e\u814e\u75c7\u72b6\u3092\u5448\u3057\u3001\u9032\u884c\u6027\u306b\u814e\u6a5f\u80fd\u304c\u4f4e\u4e0b\u3059\u308b\u907a\u4f1d\u6027\u814e\u75be\u60a3\u3067\u3059\u3002\u672c\u75c7\u306f\u3001\u2163\u578b\u30b3\u30e9\u30fc\u30b2\u30f3\u3092\u30b3\u30fc\u30c9\u3059\u308b\u907a\u4f1d\u5b50\u306e\u7570\u5e38\u306b\u3088\u3063\u3066\u7cf8\u7403\u4f53\u57fa\u5e95\u819c\u306e\u69cb\u9020\u304c\u7834\u7dbb\u3057\u3001\u814e\u6a5f\u80fd\u969c\u5bb3\u3092\u5f15\u304d\u8d77\u3053\u3057\u307e\u3059\u3002\u91cd\u75c7\u4f8b\u3067\u306f\u7537\u6027\u306710\u4ee3\u5f8c\u534a\u304b\u308920\u4ee3\u524d\u534a\u306b\u672b\u671f\u814e\u4e0d\u5168\u306b\u9032\u884c\u3057\u3066\u3057\u307e\u3046\u75be\u60a3\u3067\u3001\u96e3\u8074\u3084\u773c\u75c7\u72b6\u3092\u5408\u4f75\u3059\u308b\u3053\u3068\u3082\u7279\u5fb4\u3067\u3059\u3002\u5c0f\u5150\u6162\u6027\u814e\u75be\u60a3\u306f\u6210\u9577\u3084\u767a\u9054\u306b\u5927\u304d\u306a\u5f71\u97ff\u3092\u53ca\u307c\u3059\u305f\u3081\u3001\u793e\u4f1a\u7684\u306b\u3082\u91cd\u8981\u306a\u8ab2\u984c\u3068\u306a\u3063\u3066\u3044\u307e\u3059\u3002AS\u306f\u5e0c\u5c11\u96e3\u75c5\uff08\u96e3\u75c5\u6307\u5b9a218\uff09\u306b\u5206\u985e\u3055\u308c\u3001\u672c\u75be\u60a3\u306b\u5bfe\u3059\u308b\u6839\u672c\u7684\u306a\u6cbb\u7642\u6cd5\u306f\u78ba\u7acb\u3055\u308c\u3066\u304a\u3089\u305a\u3001\u5927\u304d\u306a\u30a2\u30f3\u30e1\u30c3\u30c8\u30cb\u30fc\u30ba\u304c\u5b58\u5728\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n<p><strong>\u30ec\u30ca\u30ea\u30b9\u30d5\u30a1\u30fc\u30de\u682a\u5f0f\u4f1a\u793e\u306b\u3064\u3044\u3066<br><\/strong>\u30ec\u30ca\u30ea\u30b9\u30d5\u30a1\u30fc\u30de\u306f\u3001\u65e5\u672c\u304a\u3088\u3073\u30a2\u30b8\u30a2\u306e\u814e\u95a2\u9023\u75be\u60a3\u306b\u304a\u3051\u308b\u30a2\u30f3\u30e1\u30c3\u30c8\u30cb\u30fc\u30ba\u306b\u5fdc\u3048\u308b\u9769\u65b0\u7684\u306a\u6cbb\u7642\u85ac\u306e\u958b\u767a\u306b\u53d6\u308a\u7d44\u3080\u7814\u7a76\u958b\u767a\u578b\u306e\u88fd\u85ac\u4f01\u696d\u3067\u3059\u3002\u30d9\u30f3\u30c1\u30e3\u30fc\u30ad\u30e3\u30d4\u30bf\u30eb\u3067\u3042\u308b\u30ad\u30e3\u30bf\u30ea\u30b9\u30d1\u30b7\u30d5\u30a3\u30c3\u30af\u304a\u3088\u3073SR One\u306b\u3088\u308a\u8a2d\u7acb\u3055\u308c\u3001\u6628\u4eca\u5897\u52a0\u306e\u4e00\u9014\u3092\u8fbf\u308b\u300c\u30c9\u30e9\u30c3\u30b0\u30fb\u30ed\u30b9\u300d\u306e\u89e3\u6d88\u3092\u76ee\u6307\u3057\u3001\u65e5\u672c\u304a\u3088\u3073\u30a2\u30b8\u30a2\u5730\u57df\u306e\u814e\u75be\u60a3\u306e\u60a3\u8005\u3055\u3093\u306b\u65b0\u305f\u306a\u6cbb\u7642\u3078\u306e\u30a2\u30af\u30bb\u30b9\u3092\u3082\u305f\u3089\u3059\u6a4b\u6e21\u3057\u5f79\u3068\u3057\u3066\u3001\u3088\u308a\u826f\u3044\u533b\u7642\u3092\u5c4a\u3051\u308b\u3053\u3068\u3092\u76ee\u6307\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n<p>\u4f1a\u793e\u540d\uff1a\u30ec\u30ca\u30ea\u30b9\u30d5\u30a1\u30fc\u30de\u682a\u5f0f\u4f1a\u793e\u3000\uff3b\u82f1\u8a9e\u540d\uff1aRenalys Pharma, Inc. \uff3d<br>\u6240\u5728\u5730\uff1a\u6771\u4eac\u90fd\u4e2d\u592e\u533a\u65e5\u672c\u6a4b\u672c\u753a\u4e8c\u4e01\u76ee3\u756a11\u53f7<br>\u4ee3\u8868\u8005\uff1aBT\u30b9\u30ea\u30f3\u30b0\u30b9\u30d3\u30fc<br>\u8a2d\u7acb\u65e5\uff1a2023\u5e744\u6708<br>URL\uff1a<a href=\"https:\/\/renalys.com\/\">https:\/\/renalys.com\/<\/a><\/p>\n\n\n\n<p>\uff1c\u6ce8\u610f\u4e8b\u9805\uff1e<br>\u672c\u30ea\u30ea\u30fc\u30b9\u306b\u8a18\u8f09\u3055\u308c\u3066\u3044\u308b\u533b\u85ac\u54c1\u306b\u95a2\u3059\u308b\u60c5\u5831\u306f\u5f53\u793e\u306e\u7d4c\u55b6\u60c5\u5831\u306e\u958b\u793a\u3092\u76ee\u7684\u3068\u3057\u3066\u304a\u308a\u3001\u5f53\u8a72\u533b\u85ac\u54c1\u306e\u5ba3\u4f1d\u30fb\u5e83\u544a\u3092\u76ee\u7684\u3068\u3059\u308b\u3082\u306e\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/p>\n\n\n\n<p>\uff1c\u672c\u4ef6\u306b\u5bfe\u3059\u308b\u304a\u554f\u3044\u5408\u308f\u305b\u5148\uff1e<br>\u30ec\u30ca\u30ea\u30b9\u30d5\u30a1\u30fc\u30de\u5e83\u5831\u4e8b\u52d9\u5c40\uff08\u682a\u5f0f\u4f1a\u793e\u30b3\u30b9\u30e2\u30fb\u30d4\u30fc\u30a2\u30fc\u30eb\u5185\uff09<br><a href=\"mailto:renalys_pr@cosmopr.co.jp\">renalys_pr@cosmopr.co.jp<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u30ec\u30ca\u30ea\u30b9\u30d5\u30a1\u30fc\u30de\u682a\u5f0f\u4f1a\u793e\uff08\u672c\u793e\uff1a\u6771\u4eac\u90fd\u4e2d\u592e\u533a\u3001\u4ee5\u4e0b\u300c\u30ec\u30ca\u30ea\u30b9\u30d5\u30a1\u30fc\u30de\u300d\uff09\u306fsparsentan\uff08\u958b\u767a\u30b3\u30fc\u30c9\uff1aRE-021\uff09\u306e\u5de3\u72b6\u5206\u7bc0\u6027\u7cf8\u7403\u4f53\u786c\u5316\u75c7\uff08FSGS\uff09\u306e\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305f\u7b2cIII\u76f8\u81e8\u5e8a\u8a66\u9a13\u53ca\u3073\u30a2\u30eb\u30dd\u30fc\u30c8\u75c7\u5019\u7fa4\uff08AS [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":412,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[8],"tags":[],"class_list":["post-541","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-8"],"_links":{"self":[{"href":"https:\/\/accelyspharma.com\/ja\/wp-json\/wp\/v2\/posts\/541","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/accelyspharma.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/accelyspharma.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/accelyspharma.com\/ja\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/accelyspharma.com\/ja\/wp-json\/wp\/v2\/comments?post=541"}],"version-history":[{"count":0,"href":"https:\/\/accelyspharma.com\/ja\/wp-json\/wp\/v2\/posts\/541\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/accelyspharma.com\/ja\/wp-json\/wp\/v2\/media\/412"}],"wp:attachment":[{"href":"https:\/\/accelyspharma.com\/ja\/wp-json\/wp\/v2\/media?parent=541"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/accelyspharma.com\/ja\/wp-json\/wp\/v2\/categories?post=541"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/accelyspharma.com\/ja\/wp-json\/wp\/v2\/tags?post=541"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}